We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current APVO market cap is 426.77k. The company's latest EPS is USD -32.6376 and P/E is -0.02.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -7.68M | -7.76M | -8.18M | -6.56M | -6.38M |
Net Income | -4.64M | 2.77M | -7.95M | -6.33M | -5.9M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 32.42M | 4.31M | 12.29M | 3.11M | 0 |
Operating Income | -42.6M | -27.49M | -21.4M | -28.64M | -28.88M |
Net Income | -40.45M | -17.75M | -28.46M | 8.03M | -17.41M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 34.22M | 34.97M | 28.91M | 27.13M | 24.84M |
Total Liabilities | 16.24M | 11.71M | 12.66M | 12.41M | 12.62M |
Total Equity | 17.97M | 23.26M | 16.25M | 14.72M | 12.22M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 53.41M | 53.55M | 56.6M | 34.22M | 24.84M |
Total Liabilities | 41.57M | 36.95M | 55.39M | 16.24M | 12.62M |
Total Equity | 11.84M | 16.59M | 1.22M | 17.97M | 12.22M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -21.02M | 4.57M | -237k | -6.48M | -11.73M |
Investing | -29k | N/A | N/A | N/A | N/A |
Financing | -2.62M | -1.87M | -1.39M | 2.95M | 6M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -42.38M | -29.32M | -21.68M | -21.02M | -11.73M |
Investing | 4.1M | 28.03M | -713k | -29k | N/A |
Financing | 20.15M | 23.87M | 26.16M | -2.62M | 6M |
Market Cap | 426.77k |
Price to Earnings Ratio | -0.02 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.02 |
Price to Book Ratio | 0.03 |
Dividend Yield | - |
Shares Outstanding | 533.46k |
Average Volume (1 week) | 150.75k |
Average Volume (1 Month) | 182.04k |
52 Week Change | -98.84% |
52 Week High | 80.96 |
52 Week Low | 0.67 |
Spread (Intraday) | 0.01 (1.3%) |
Company Name | Aptevo Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.aptevotherapeutics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions